Investing Profile

Elena Viboch

InvestorVC
Managing Director at General Catalyst
generalcatalyst.comSan Francisco Bay Area
Photo of Elena Viboch, Managing Director at General Catalyst

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture
Picture

2 Investors

Connected to Saar Gur (CRV), Lisa Marrone (Pivotal bioVenture Partners).

NewCo Network
1586 CONNECTIONS
NewCo Network
1586 CONNECTIONS
Top-Patents Network
1028 CONNECTIONS
Top-Patents Network
1028 CONNECTIONS
The Johns Hopkins University Network
67 CONNECTIONS
cb
General Catalyst Managing Director
$500K - $2.0M
$500K
28
$1.1B
CompanyStageDateRound SizeTotal Raised
Parabilis Medicines
Series FJan 2026$310M
Series EMar 2024$150M
$800M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Corey Goodman (venBio), Thilo Schroeder (Nextech Invest), Jake Simson (RA Capital)
Chai Discovery
Series BDec 2025$130M
$230M
Co-investors: Fred Ehrsam (Paradigm), Hemant Taneja (General Catalyst), Greg Yap (Menlo Ventures), Lachy Groom (Physical Intelligence), Annie Lamont (Oak HC/FT), Nitesh Banta (Stellar Capital)
Paradigm
Series BDec 2025$78M
Series AJan 2023$200M
$320M
Co-investors: David Schenkein (GV (Google Ventures)), Hemant Taneja (General Catalyst), Ramnik Arora (FTX Ventures), Max Rimpel (Index Ventures), Niko Bonatsos (General Catalyst), Bilal Zuberi (Lux Capital), Brett Cook (F-Prime Capital Partners), Stephen Knight (F-Prime Capital Partners), Jay Markowitz (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Alaa Halawa (Mubadala), Justin Kao (DFJ Growth), Jared Friedman (Israel Defense Forces), Scott Belsky (A24), Balaji Srinivasan, Arash Ferdowsi, Eoghan McCabe, Karim Atiyeh
Tahoe Therapeutics
Series AAug 2025$30M
SeedDec 2022$12M
$42M
Co-investors: Gaurav Garg (Wing Venture Capital), Deep Nishar (SoftBank Investment Advisers), Sunil Dhaliwal (Amplify Partners), Krish Ramadurai (Harmonix Fund), Ayman AlAbdallah
Maxion Therapeutics
Series AMar 2025$75M
$91M
Co-investors: Lucy Edwardes-Jones (Business Growth Fund)
Eikon Therapeutics
Series DFeb 2025$350M
Series BJan 2022$520M
$1B
Co-investors: Josh Wolfe (Lux Capital), Larry Lasky (The Column Group), Leon Chen (The Column Group), Adam Goulburn (Dimension Capital), Eric Schmidt (Innovation Endeavors), Dror Berman (Innovation Endeavors)
Manas AI
SeedJan 2025$26M
$26M
Co-investors: Hemant Taneja (General Catalyst), Reid Hoffman (Greylock)
Medeloop
Series ANov 2024$16M
SeedSep 2023$8M
$24M
Co-investors: Sara Thomas Deshpande (Maven Ventures), Magaly Charbonneau (iNovia Capital)
Managing Director General Catalyst2024 - Present
Director of Business Development & Operations FLX Bio, Inc.Present
Director of Business Development & Operations NewCoPresent
Senior Manager, Corporate Development & Strategy NewCoPresent
Managing Director General Catalyst PartnersPresent
Partner General Catalyst PartnersPresent
Director of Business Development & Operations Top-PatentsPresent
Senior Manager, Corporate Development & Strategy Top-PatentsPresent
Consultant PutnamPresent
Partner General Catalyst2022 - 2024
Investment Director SoftBank Investment Advisers2019 - 2022
Director of Corporate Development NanoString Technologies, Inc.2017 - 2019
Director of Business Development & Operations Carmot Therapeutics2016 - 2017
Senior Manager, Corporate Development & Strategy FLX Bio, Inc.2015 - 2016
Corporate Development Jazz Pharmaceuticals2014 - 2014
Investor Kearny Venture Partners2011 - 2014
Consultant Putnam Associates2009 - 2011
The Johns Hopkins University Master of Science - MS Biotechnology